microbiology, Vol 143, 2381-2394, Copyright © 1997 by Society for General Microbiology

ARTICLES

Tn5-induced lipopolysaccharide mutations in Bordetella pertussis that affect outer membrane function

ML Turcotte, D Martin, BR Brodeur and MS Peppler
Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada.

An LPSB-specific mAb was used to screen for ten Tn5 insertion mutants of Bordetella pertussis which have LPS which is phenotypically distinct from either wild-type LPSAB or LPSB. Silver-strained SDS-PAGE gels showed nine different LPS phenotypes, six of which contain two clinically undocumented LPS bands, designated IntA and IntB based on their proximity to the LPSA and LPSB bands, respectively. Binding assays with LPSA- and LPSB-specific mAbs established changes in epitope exposure for the various mutant LPS, both in cell-free form and as presented on the surface of whole cells. The possible involvement of a number of genes, both structural and regulatory, was indicated in production of the altered phenotypes. PFGE and Southern blotting showed that the Tn5 inserts of seven mutants mapped to a region of the B. pertussis chromosome shown previously to encode the bpl gene products of LPS biosynthesis. Mutants MLT3, MLT5 and MLT8, however, mapped to distinctly different parts of the chromosome. In addition, mutants MLT2 and MLT3 contributed to an accelerated frequency in the appearance of avirulent phase organisms despite their Tn5 inserts being over 1000 bp from the bvglASR locus. The alterations in LPS structure in the mutants changed their reactivity to strain-specific mAbs and their sensitivity to hydrophobic and hydrophilic antibiotics.

This article has been cited by other articles:

				T. Niedziela, I. Letowska, J. Lukasiewicz, M. Kaszowska, A. Czarnecka, L. Kenne, and C. Lugowski Epitope of the Vaccine-Type Bordetella pertussis Strain 186 Lipooligosaccharide and Antiendotoxin Activity of Antibodies Directed against the Terminal Pentasaccharide-Tetanus Toxoid Conjugate Infect. Immun., November 1, 2005; 73(11): 7381 - 7389. [Abstract] [Full Text] [PDF]

				L. M. Schaeffer, F. X. McCormack, H. Wu, and A. A. Weiss Bordetella pertussis Lipopolysaccharide Resists the Bactericidal Effects of Pulmonary Surfactant Protein A J. Immunol., August 1, 2004; 173(3): 1959 - 1965. [Abstract] [Full Text] [PDF]

				B. Fuchslocher, L. L. Millar, and P. A. Cotter Comparison of bipA Alleles within and across Bordetella Species Infect. Immun., June 1, 2003; 71(6): 3043 - 3052. [Abstract] [Full Text] [PDF]

				L. M. Schaeffer and A. A. Weiss Pertussis Toxin and Lipopolysaccharide Influence Phagocytosis of Bordetella pertussis by Human Monocytes Infect. Immun., December 1, 2001; 69(12): 7635 - 7641. [Abstract] [Full Text] [PDF]

				A. Preston and D. Maskell Invited review: The molecular genetics and role in infection of lipopolysaccharide biosynthesis in the Bordetellae Innate Immunity, August 1, 2001; 7(4): 251 - 261. [PDF]

				E. T. Harvill, A. Preston, P. A. Cotter, A. G. Allen, D. J. Maskell, and J. F. Miller Multiple Roles for Bordetella Lipopolysaccharide Molecules during Respiratory Tract Infection Infect. Immun., December 1, 2000; 68(12): 6720 - 6728. [Abstract] [Full Text] [PDF]

				C. L. Weingart and A. A. Weiss Bordetella pertussis Virulence Factors Affect Phagocytosis by Human Neutrophils Infect. Immun., March 1, 2000; 68(3): 1735 - 1739. [Abstract] [Full Text] [PDF]

				A. A. Weiss, P. S. Mobberley, R. C. Fernandez, and C. M. Mink Characterization of Human Bactericidal Antibodies to Bordetella pertussis Infect. Immun., March 1, 1999; 67(3): 1424 - 1431. [Abstract] [Full Text] [PDF]

				A. Banemann, H. Deppisch, and R. Gross The Lipopolysaccharide of Bordetella bronchiseptica Acts as a Protective Shield against Antimicrobial Peptides Infect. Immun., December 1, 1998; 66(12): 5607 - 5612. [Abstract] [Full Text] [PDF]